Detalhe da pesquisa
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652353
2.
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.
Infect Dis Ther
; 13(4): 699-714, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489117
3.
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Vaccine
; 41(13): 2137-2146, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828719
4.
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
Vaccine
; 40(1): 162-172, 2022 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507861